Octave Bioscience

Menlo Park, CA · Founded 2014 · Privately Held (backing)

Operator of a biomarker-driven precision medicine company intended to improve monitoring and treatment decisions for neurodegenerative diseases. Octave Bioscience is based in Menlo Park, CA and was founded in 2014. Its last reported valuation was $143 million in Jul 2023. It has raised $129 million across 5 recorded rounds; the latest was a $31.8 million early-stage round in Mar 2025.

Last reported valuation
$143.0M
Oct 2026
Priced at
—
Total raised
$129.2M
Last round
Early Stage VC
Mar 2025
How much has Octave Bioscience raised?
$129.2Macross 5 recorded rounds · Nov 2014 – Mar 2025

Most recently, Octave Bioscience raised $31.8M in its Early Stage VC (Mar 2025).

Free account
More of Octave Bioscience with a free account
  • ·The complete investor list: 18 names
  • ·Watch Octave Bioscience: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Octave Bioscience round by round

5 rounds
Mar 2025Early Stage VC$31.8MSEC filing▮
20 investors participated
Sep 2023Early Stage VC$7.0MSEC filing▮
2 investors participated
Jan 2023Early Stage VC$32.5MSEC filing▮
20 investors participated
Oct 2020Early Stage VC$32.0MSEC filing▮
14 investors participated
Nov 2014Seed Round$2.5MSEC filing▮
7 investors participated

How much has Octave Bioscience raised?

Octave Bioscience has raised $129 million across 5 recorded rounds since 2014. The largest was a $7 million early-stage round in Sep 2023; the most recent was a $31.8 million early-stage round in Mar 2025.

Octave Bioscience has filed 5 Form Ds with the SEC since 2017, most recently in Mar 2025 ($31.8 million sold to 20 investors).

Octave Bioscience investors

18 investors are on record for Octave Bioscience, including European Innovation Council, Kleiner Perkins, S32 and Deerfield Management. By type, the record holds 7 venture capital firms. The early-stage round in Mar 2025 drew 20 investors.

For fundraisers
Raising for a company like Octave Bioscience?

18 investors have backed Octave Bioscience.

See all 18 investors →

Frequently asked about Octave Bioscience

How much has Octave Bioscience raised?
Octave Bioscience has raised $129.2M in total across 5 recorded funding rounds.
When was Octave Bioscience's last funding round?
Octave Bioscience's most recent recorded round was Early Stage VC in Mar 2025, raising $31.8M.